Detalhe da pesquisa
1.
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.
Ann Intern Med
; 176(12): 1577-1585, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37956428
2.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis
; 76(3): e526-e529, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35737946
3.
Viral Lineages in the 2022 RSV Surge in the United States.
N Engl J Med
; 388(14): 1335-1337, 2023 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36812457
4.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med
; 387(3): 275-277, 2022 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35767428
5.
Implementation of a SARS-CoV-2 Genotyping Panel for Prompt Omicron Variant Identification: A Pragmatic Tool for Clinical Laboratories.
Ann Intern Med
; 175(6): 906-908, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35344374
6.
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.
Sci Transl Med
; 16(731): eadk1599, 2024 Jan 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38266109
7.
Neuropathological features of SARS-CoV-2 delta and omicron variants.
J Neuropathol Exp Neurol
; 82(4): 283-295, 2023 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36847705
8.
The 2022 RSV surge was driven by multiple viral lineages.
medRxiv
; 2023 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36656774
9.
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy.
medRxiv
; 2023 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37425934
10.
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency.
medRxiv
; 2023 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37577493
11.
CD8+ lymphocytes are critical for early control of tuberculosis in macaques.
J Exp Med
; 220(12)2023 12 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37843832
12.
Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay.
Open Forum Infect Dis
; 9(3): ofac022, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35169591
13.
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
JCI Insight
; 7(2)2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34871181
14.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
JCI Insight
; 7(19)2022 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36214224
15.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
medRxiv
; 2022 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35262089
16.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
medRxiv
; 2022 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35262094
17.
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.
Cell Rep Med
; 3(4): 100583, 2022 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35480627
18.
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.
medRxiv
; 2021 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34642698